BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211,252,590 | -21.1% | 8,783,891 | +4.8% | 1.62% | -8.8% |
| Q2 2023 | $267,656,246 | +2.0% | 8,382,595 | -2.2% | 1.77% | -1.8% |
| Q1 2023 | $262,518,396 | -18.3% | 8,573,429 | +4.4% | 1.80% | -35.2% |
| Q4 2022 | $321,215,553 | -20.6% | 8,213,131 | -3.3% | 2.78% | -1.2% |
| Q3 2022 | $404,508,000 | +30.8% | 8,490,936 | -3.4% | 2.82% | +54.1% |
| Q2 2022 | $309,305,000 | -34.2% | 8,792,064 | +7.2% | 1.83% | -6.8% |
| Q1 2022 | $469,903,000 | -26.1% | 8,200,749 | +2.7% | 1.96% | +2.0% |
| Q4 2021 | $636,197,000 | +6.9% | 7,983,401 | +16.7% | 1.92% | +34.5% |
| Q3 2021 | $595,298,000 | -28.4% | 6,841,722 | +5.9% | 1.43% | -7.6% |
| Q2 2021 | $831,643,000 | +117.4% | 6,461,367 | +35.2% | 1.55% | +103.7% |
| Q1 2021 | $382,519,000 | +314.0% | 4,779,104 | +322.3% | 0.76% | +208.9% |
| Q4 2020 | $92,386,000 | – | 1,131,623 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |